ES2080621T3 - Preparacion de uso cutaneo. - Google Patents

Preparacion de uso cutaneo.

Info

Publication number
ES2080621T3
ES2080621T3 ES93914485T ES93914485T ES2080621T3 ES 2080621 T3 ES2080621 T3 ES 2080621T3 ES 93914485 T ES93914485 T ES 93914485T ES 93914485 T ES93914485 T ES 93914485T ES 2080621 T3 ES2080621 T3 ES 2080621T3
Authority
ES
Spain
Prior art keywords
preparation
filters
cutaneous use
cutaneous
drug vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93914485T
Other languages
English (en)
Spanish (es)
Inventor
Josette Olivier-Terras
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cosmetics Development Co Ltd
Original Assignee
Cosmetics Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmetics Development Co Ltd filed Critical Cosmetics Development Co Ltd
Application granted granted Critical
Publication of ES2080621T3 publication Critical patent/ES2080621T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
ES93914485T 1992-01-16 1993-01-06 Preparacion de uso cutaneo. Expired - Lifetime ES2080621T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200619A FR2686249A1 (fr) 1992-01-16 1992-01-16 Preparation a usage cutane a base de liposomes.

Publications (1)

Publication Number Publication Date
ES2080621T3 true ES2080621T3 (es) 1996-02-01

Family

ID=9425847

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93914485T Expired - Lifetime ES2080621T3 (es) 1992-01-16 1993-01-06 Preparacion de uso cutaneo.

Country Status (8)

Country Link
US (1) US5554374A (enExample)
EP (1) EP0625039B1 (enExample)
JP (1) JPH07505862A (enExample)
AU (1) AU672191B2 (enExample)
DE (1) DE69300521T2 (enExample)
ES (1) ES2080621T3 (enExample)
FR (1) FR2686249A1 (enExample)
WO (1) WO1993013742A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732215B1 (fr) * 1995-03-28 1997-04-30 Sederma Sa Nouvelles compositions cosmetiques depigmentantes
IL119224A (en) * 1996-09-09 2002-11-10 Hadasit Med Res Service Medicament for protection from effects of irradiation
DE19812777A1 (de) * 1998-03-24 1999-10-07 Henkel Kgaa Verfahren zur beschleunigten Aufnahme vom Carotinoiden in Serum und Gewebe
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
ATE353210T1 (de) * 1999-05-25 2007-02-15 Sol Gel Technologies Ltd Ein verfahren zur herstellung von einem lichtstabilen sonnenschutzmittel
US7468195B2 (en) * 2000-06-09 2008-12-23 Crawford Healthcare Limited Skin treatment preparation
JP2002138013A (ja) * 2000-10-27 2002-05-14 Pias Arise Kk Ｈｎｅ・アクロレインの生成抑制・分解促進剤及び皮膚抗老化外用剤
US6830746B2 (en) 2001-09-21 2004-12-14 Playtex Products, Inc. Sunscreen compositions
EP2135598B1 (en) * 2008-06-16 2011-08-03 Rohm and Haas Company Particle Containing Ultraviolet Absorber
FR2956977A1 (fr) * 2010-03-03 2011-09-09 Emulscience Composition cosmetique anti-age, utilisation et procede d'application correspondant
CA2961868A1 (en) * 2016-04-08 2017-10-08 Johnson & Johnson Consumer Inc. Topical compositions containing cross-linked glycosaminoglycans

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
EP0381543B1 (en) * 1989-01-31 1993-05-26 Coletica Use of solutions of atelocollagen and polyholosides, for example glycosaminoglycans, for the manufacture of microcapsules, microcapsules produced in this way, processes for the manufacture of such microcapsules and cosmetic, pharmaceutical or food compositions in which they are present
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.

Also Published As

Publication number Publication date
JPH07505862A (ja) 1995-06-29
EP0625039A1 (fr) 1994-11-23
FR2686249B1 (enExample) 1995-06-02
AU672191B2 (en) 1996-09-26
DE69300521T2 (de) 1996-02-22
US5554374A (en) 1996-09-10
FR2686249A1 (fr) 1993-07-23
AU3455393A (en) 1993-08-03
DE69300521D1 (de) 1995-10-26
EP0625039B1 (fr) 1995-09-20
WO1993013742A1 (fr) 1993-07-22

Similar Documents

Publication Publication Date Title
ATE189228T1 (de) Peptide mit zyklischen hauptketten, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
ES2131504T3 (es) Trombina humana purificada viricamente segura.
ATE73331T1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
FI103867B1 (fi) Menetelmä di-linoleoyyli-mono-gamma-linolenyyli-glyserolia sisältävän, farmaseuttisesti käyttökelpoisen öljyn valmistamiseksi
ES2080621T3 (es) Preparacion de uso cutaneo.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
SE8204874D0 (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
DE59001281D1 (de) Oxidierte diphenylheteroalkane, ihre herstellung und verwendung.
ES2064642T3 (es) Peptidos hemorreguladores.
ES2090066T3 (es) Preparaciones externas que contienen agua y propionato de deprodona.
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
ES2072536T3 (es) Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
DK2886A (da) Dopamin-beta-hydroxylaseinhibitorer
IT1250659B (it) Procedimento di purificazione di carragenine commerciali
DE69125024D1 (de) Lhrh-antagonisten
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
DK0437225T3 (da) Topiske præparater
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
SE8704240D0 (sv) Analgesic preparations
IT7922548A0 (it) Derivati del 1,5-dimetilbiciclo(3.2.1.)-ottano, preparazione di questi composti eloro impiego come composti per profumi.
ES2051898T3 (es) Composicion farmaceutica para 4-aroilimidazol-2-onas.
SE8204872D0 (sv) Farmaceutiska preparat, innefattande humant insulin, human c-peptid och humant proinsulin

Legal Events

Date Code Title Description
FC2A Grant refused

Effective date: 19931216

FG2A Definitive protection

Ref document number: 625039

Country of ref document: ES